246 related articles for article (PubMed ID: 12101604)
1. [The cynical game of the tobacco industry. Many years' efforts to deny or cover-up the negative effects of tobacco are revealed by the forced publication of internal documents].
Lambe M; Hallhagen E; Boëthius G
Lakartidningen; 2002 Jun; 99(24):2756-62. PubMed ID: 12101604
[TBL] [Abstract][Full Text] [Related]
2. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
3. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
Muggli ME; Hurt RD; Becker LB
Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
[TBL] [Abstract][Full Text] [Related]
4. [Swedish Match on the criticism: tobacco research will suffer].
Aulin B
Lakartidningen; 2002 Jul; 99(28-29):3052-4. PubMed ID: 12170520
[No Abstract] [Full Text] [Related]
5. The tobacco industry's worldwide ETS consultants project: European and Asian components.
Barnoya J; Glantz SA
Eur J Public Health; 2006 Feb; 16(1):69-77. PubMed ID: 16076855
[TBL] [Abstract][Full Text] [Related]
6. The Philip Morris Nordic journalist program: strategies, implementation and outcomes.
Hiilamo H; Kahl U; Lambe M
Health Policy; 2009 Jan; 89(1):84-96. PubMed ID: 18582983
[TBL] [Abstract][Full Text] [Related]
7. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease.
Tong EK; Glantz SA
Circulation; 2007 Oct; 116(16):1845-54. PubMed ID: 17938301
[TBL] [Abstract][Full Text] [Related]
8. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972.
Schick S; Glantz S
Nicotine Tob Res; 2005 Aug; 7(4):591-612. PubMed ID: 16085530
[TBL] [Abstract][Full Text] [Related]
9. Tobacco control implications of the first European product liability suit.
Hiilamo HT
Tob Control; 2005 Feb; 14(1):22-30. PubMed ID: 15735296
[TBL] [Abstract][Full Text] [Related]
10. Courtesy and the challenges of implementing smoke-free policies in Japan.
Bialous SA; Mochizuki-Kobayashi Y; Stillman F
Nicotine Tob Res; 2006 Apr; 8(2):203-16. PubMed ID: 16766413
[TBL] [Abstract][Full Text] [Related]
11. The tobacco industry and secondhand smoke: lessons from Central and South America.
Barnoya J; Glantz SA
Ethn Dis; 2003; 13(2 Suppl 2):S88-90. PubMed ID: 13677420
[TBL] [Abstract][Full Text] [Related]
12. Implications of the tobacco industry documents for public health and policy.
Bero L
Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
[TBL] [Abstract][Full Text] [Related]
13. Where there's no smoke: popular smoke-free laws curbing active, passive smoking.
Twombly R
J Natl Cancer Inst; 2004 Jul; 96(14):1058-60. PubMed ID: 15265964
[No Abstract] [Full Text] [Related]
14. Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study.
Ong EK; Glantz SA
Lancet; 2000 Apr; 355(9211):1253-9. PubMed ID: 10770318
[TBL] [Abstract][Full Text] [Related]
15. Endotoxins in tobacco smoke: shifting tobacco industry positions.
Barnes RL; Glantz SA
Nicotine Tob Res; 2007 Oct; 9(10):995-1004. PubMed ID: 17852769
[TBL] [Abstract][Full Text] [Related]
16. Oklahoma tobacco policy-making.
Givel M
J Okla State Med Assoc; 2005 Mar; 98(3):89-94. PubMed ID: 15822722
[TBL] [Abstract][Full Text] [Related]
17. Tobacco industry research and efforts to manipulate smoke particle size: implications for product regulation.
Wayne GF; Connolly GN; Henningfield JE; Farone WA
Nicotine Tob Res; 2008 Apr; 10(4):613-25. PubMed ID: 18418784
[TBL] [Abstract][Full Text] [Related]
18. Tobacco industry sponsorship of a book and conflict of interest.
Hong MK; Bero LA
Addiction; 2006 Aug; 101(8):1202-11. PubMed ID: 16869850
[TBL] [Abstract][Full Text] [Related]
19. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.
Bitton A; Neuman MD; Barnoya J; Glantz SA
Lancet; 2005 Feb 5-11; 365(9458):531-40. PubMed ID: 15705463
[TBL] [Abstract][Full Text] [Related]
20. [Naivety of researchers' and physicians' contacts with tobacco industry. Only a few are aware of the manipulation they are exposed to by well-conducted campaigns].
Pershagen G
Lakartidningen; 2002 Jun; 99(24):2726-8. PubMed ID: 12101596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
